Additional file 1 of Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
收藏数据链接：
官方服务：
资源简介：
Additional file 1: Supplementary Table 1a. Association of PFS with selected variables. Supplementary Table 1b Association of PFS with selected variables in multivariable analysis – Paired analysis.
提供机构：
Ludek Pour创建时间：
2021-01-16
